Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma-Reference-Cited by-同舟云学术

Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma

Published:2018-09 Issue:5 Volume:198 Page:610-619
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Lightwood Daniel¹,Tservistas Markus²,Zehentleitner Monique²,Sarkar Kaushik¹,Turner Alison¹,Bracher Marguerite¹,Smith Bryan¹,Lamour Sabrina¹,Bourne Tim¹,Shaw Stevan¹,Gozzard Neil¹,Palframan Roger T.¹

Affiliation:

1. UCB Pharma, Slough, Berkshire, United Kingdom; and

2. PARI Pharma GmbH, Gräfelfing, Germany

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201712-2382OC

Reference50 articles.

1. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma

2. Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease

3. Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes

4. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

5. The Contribution of Interleukin (IL)-4 and IL-13 to the Epithelial–Mesenchymal Trophic Unit in Asthma

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologikatherapie in der Behandlung der atopischen Dermatitis und des Asthma bronchiale;Kinder- und Jugendmedizin;2024-06

2. Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases;Expert Opinion on Drug Delivery;2023-08-03

3. Inhaled drug delivery for the targeted treatment of asthma;Advanced Drug Delivery Reviews;2023-07

4. Development of an inhaled anti-TSLP therapy for asthma;Pulmonary Pharmacology & Therapeutics;2023-02

5. Pulmonary Delivery of Antibody for the Treatment of Respiratory Diseases;AAPS Introductions in the Pharmaceutical Sciences;2023